Literature DB >> 31945285

[Cardiovascular autonomic neuropathy in the course of diabetes - the review of actual knowledge.]

Beata Kieć-Wilk1, Joanna Gastoł2, Łukasz Pawliński3.   

Abstract

Diabetic neuropathy, including autonomic cardiovascular neuropathy, is the most common chronic complication of diabetes. It causes serious health and social consequences, leading to a significant reduction of life expectancy in DM patients. Its development is initially asymptomatic and therefore often underestimated, and only the early detection of diabetic neuropathy gives a real chance to stop its progression and prevent irreversible damage to the nerves. The optimal glycemic control is the most important factor preventing the development of neuropathy, inhibiting its occurrence and progression. In the advanced stage, however, only symptomatic treatment remains. The article provides an overview of current knowledge about etiopathogenesis, therapy, symptoms and the latest clinical trials on NSN and DM.

Entities:  

Year:  2019        PMID: 31945285     DOI: 10.18388/pb.2019_287

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  1 in total

1.  The Outcomes of Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2I) on Diabetes-Associated Neuropathy: A Systematic Review and meta-Analysis.

Authors:  Mahmoud Kandeel
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.